Welcome to our dedicated page for Tenet Healthcare news (Ticker: THC), a resource for investors and traders seeking the latest updates and insights on Tenet Healthcare stock.
Tenet Healthcare Corporation reports developments across a diversified healthcare services business that combines ambulatory surgery, hospital operations and healthcare-services outsourcing. Its care delivery network includes United Surgical Partners International, which operates ambulatory surgery centers and surgical hospitals, along with acute care and specialty hospitals, outpatient facilities, employed physician networks and a global business center in Manila.
Recurring news themes for THC include quarterly earnings, financial outlooks, same-facility revenue trends, Ambulatory and Hospital segment performance, payer-mix and expense-management commentary, and capital or ownership actions involving Conifer Health Solutions. Company updates also cover Conifer's revenue cycle management and value-based care services for hospitals, health systems, physician practices, employers and other clients, as well as Tenet's presentations at healthcare investor conferences.
Tenet (NYSE: THC) reported third-quarter 2025 results with Q3 net income $342M ($3.86 diluted) and Adjusted diluted EPS $3.70, up 26.3% year-over-year. Consolidated Adjusted EBITDA was $1.099B, up 12.4% versus Q3 2024; Ambulatory Adjusted EBITDA was $492M, up 12.1%.
Year-to-date free cash flow was $2.163B, operating cash flow $2.809B, and net debt/Adjusted EBITDA improved to 2.30x. Tenet repurchased 0.6M shares for $93M in Q3 and 7.8M shares for $1.188B year-to-date. Management raised FY 2025 Adjusted EBITDA outlook to $4.47B–$4.57B (midpoint +$50M).
Tenet Healthcare (NYSE:THC) has scheduled the release of its Q3 2025 financial results for Tuesday, October 28, 2025, before market opening. The company will host a conference call at 9:30 a.m. CT (10:30 a.m. ET) to discuss the results. Investors can access both the live webcast and audio archive through Tenet's investor relations website.
Tenet Healthcare (NYSE:THC) announced its upcoming participation in the 2025 Wells Fargo Healthcare Conference. The presentation is scheduled for September 3, 2025, at 9:30 a.m. Eastern Time.
Investors can access the live webcast and audio archive through Tenet's investor relations website. The replay will remain available for 30 days following the presentation.
Tenet Healthcare (NYSE:THC) and its subsidiary USPI have been named foundational sponsors of the American Association of Orthopaedic Surgeons' (AAOS) inaugural Launchpad Program. The 20-month initiative is designed to support postgraduate year 5 (PGY5) orthopaedic surgery residents in their transition from residency to practice.
The program, launched as a pilot at the AAOS Annual Meeting in March 2025, will support three cohorts of PGY5 resident members over the next three and a half years. It focuses on fellowship navigation, preparation for American Board of Orthopaedic Surgery examinations, and building foundations for long-term success. AAOS plans to expand the program to include all PGY4 and PGY5 residents after the pilot phase.
Tenet Healthcare (NYSE:THC) reported strong Q2 2025 results with significant growth across key metrics. Net income reached $288 million ($3.14 per diluted share), while Adjusted EBITDA increased 18.6% to $1.121 billion with a 21.3% margin.
The company's Ambulatory Care segment showed robust performance with Adjusted EBITDA of $498 million, up 11.4% year-over-year. The Hospital segment delivered strong results with Adjusted EBITDA of $623 million, benefiting from favorable payer mix and higher acuity services.
Notably, the Board authorized a $1.5 billion increase to the share repurchase program. Tenet raised its FY 2025 outlook, now expecting Adjusted EBITDA between $4.40-$4.54 billion, a $395 million increase at the midpoint.
Tenet Healthcare Corporation (NYSE: THC) has announced its participation in the upcoming BofA Securities 2025 Health Care Conference. The company's presentation is scheduled for Tuesday, May 13, 2025, at 1:40 p.m. Eastern time. Investors and interested parties can access the live webcast through Tenet's investor relations website at www.tenethealth.com/investors. A replay of the presentation will remain available on the website for 30 days following the event.
Tenet Healthcare reported strong Q1 2025 financial results, with net income of $406 million ($4.27 per diluted share) and Adjusted EBITDA of $1.163 billion, marking a 13.6% increase from Q1 2024. The company's Ambulatory Care segment showed impressive growth with a 15.7% increase in Adjusted EBITDA to $456 million.
Key highlights include:
- Adjusted diluted EPS increased 35.4% to $4.36
- Strong cash flow of $815 million from operations
- Same-hospital admissions grew 4.4%
- Ambulatory segment revenue increased 20%
The company's 2025 outlook projects net operating revenues between $20.6-21.0 billion and Adjusted EBITDA of $3.975-4.175 billion. Tenet maintains a strong operational position with 520 ambulatory surgery centers and 25 surgical hospitals across 37 states, demonstrating continued expansion in high-quality specialty care delivery.
Tenet Healthcare (NYSE: THC) has announced it will release its first quarter 2025 financial results before market opening on Tuesday, April 29, 2025. The company will host a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time) on the same day to discuss the results. Investors can access both a live webcast and audio archive of the earnings call through the investor relations section of Tenet's website.
Tenet Healthcare (NYSE: THC) has announced its upcoming virtual participation in the Barclays 27th Annual Global Healthcare Conference. The presentation is scheduled for Wednesday, March 12, 2024, starting at 10:00 a.m. Eastern time.
Investors and interested parties can access the live webcast and audio archive through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will remain available for a 30-day period following the presentation.